Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN84,3584,380,39
Msft1,58
Nokia4,3894,48-0,27
IBM1,50
Mercedes-Benz Group AG50,1950,21-1,01
PFE0,24
04.07.2025 18:00:42
Indexy online
AD Index online
select
AD Index online
 

  • 03.07.2025 23:00:00
Inogen (NASDAQ Cons)
Závěr k 3.7.2025 Změna (%) Změna (USD) Objem obchodů (ks)
7,49 0,94 0,07 89 356
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.07.2025
Popis společnosti
Obecné informace
Název společnostiInogen Inc
TickerINGN
Kmenové akcie:Ordinary Shares
RICINGN.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 766
Akcie v oběhu k 02.05.2025 26 887 242
MěnaUSD
Kontaktní informace
Ulice859 WARD DRIVE
MěstoGOLETA
PSČ93111
ZeměUnited States
Kontatní osobaRyan Peterson
Funkce kontaktní osobyAssociate Director - Investor Relations
Telefon18 055 620 500
Fax13026365454

Business Summary: Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Inogen Inc revenues increased 5% to $82.3M. Net loss decreased 58% to $6.2M. Revenues reflect Non-U.S. revenue segment increase of 23% to $32M. Lower net loss reflects respiratory products segment loss decrease of 53% to $7.7M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.62 to -$0.25.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSoftware Publishers
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICPrepackaged Software



  • Poslední aktualizace: 05.07.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorKevin Smith5410.11.202310.11.2023
Chief Financial Officer, Executive Vice President, Corporate TreasurerMichael Bourque6204.03.202404.03.2024
Executive Vice President - Business Development, General Counsel, SecretaryKevin Smith5422.07.202422.07.2024
Executive Vice President, Chief Commercial OfficerGregoire Ramade5502.01.202402.01.2024